You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This issue of Cardiac Electrophysiology Clinics examines Arrhythmias in Cardiomyopathies. Articles include Atrial and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy and Its Variants; Role of Cardiac MRI in Risk Stratification of Hypertrophic Cardiomyopathy; Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy; Exercise-Induced Right Ventricular Cardiomyopathy; Dilated Cardiomyopathy; Sarcoidosis; Amyloidosis; Chagas Disease; Fabry Disease; Left Ventricular Hypertrophy: Ventricular Arrhythmias and SCD; Left Ventricular Non-compaction; Mitochondrial Cardiomyopathy and Related Arrhythmias; Arrhythmias in Viral Myocarditis and Pericarditis Cardiomyopathy; Takotsubo Cardiomyopathy; Post-partum Cardiomyopathy; Arrhythmias in Alcohol- and Drug-Associated Cardiomyopathies; Arrhythmias in Neuromuscular Dystrophies; Cardiomyopathies Related to Anti-cancer Therapy– and Radiation- Induced Heart Disease; Arrhythmias After Myocardial Stem Cell Therapy; and more.
The American Heart Association’s Scientific Sessions 2016 is bringing big science, big technology, and big networking opportunities to New Orleans, Louisiana this November. This event features five days of the best in science and cardiovascular clinical practice covering all aspects of basic, clinical, population and translational content.
This important issue of Medical Clinics provides essential updates in heart failure. The following topics are covered: epidemiology, pathophysiology, and general approach for heart failure; symptoms, signs, diagnostic studies, and prognostic significance of systolic versus diastolic heart failure; the appropriate use of biomarkers; oral versus intravenous diuretic therapy; guideline-based therapy including RAAS blockade, beta-blockade, and aldosterone antagonist, appropriate use of AICD and biventricular pacing; role of ventricular assist device; pathophysiological consideration and management approaches in acute decompensated heart failure; pathophysiology and current approaches to cardiorenal syndrome; heart failure with other comorbidities including diabetes, obesity, anemia, and cancer; heart failure and atrial fibrillation; and the role of disease management strategies in heart failure.
The American Heart Association’s Scientific Sessions 2019 is bringing big science, big technology, and big networking opportunities to Philadelphia, Pennsylvania this November. This event features five days of the best in science and cardiovascular clinical practice covering all aspects of basic, clinical, population and translational content.
Patients with prior autoimmune diseases such as sarcoidosis require special care when treated with checkpoint inhibitors (CPIs), given the risk for reactivation of inflammation. Here, we address the clinical dilemma of initiating CPIs for recurrent metastatic carcinoma in a patient with extensive sarcoidosis, controlled after prolonged immunosuppressive therapy when the tumor recurrence was detected. To achieve the best possible outcome, the case was discussed by an interdisciplinary team comprising specialists in rheumatology, oncology, and CPI-related myocarditis. Literature on this topic was very limited. Based on the pharmacodynamics of CPIs and the pathophysiology of CPI-related autoimmune diseases, we concluded that initiating CPIs alongside low-dose prednisolone would effectively suppress any reactivation of sarcoidosis without interfering with CPIs in a relevant way.
This official directory is a database that includes more than 742,000 physician profiles, including their board certification status. This list also features nearly 20,000 physicians in foreign countries who are certified by American specialty boards.